TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 33 filers reported holding TSCAN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STATE STREET CORP | 41,700 | $106,752 | 0.00% |
| MORGAN STANLEY | 259,447 | $664,184 | 0.00% |
| BlackRock Inc. | 1,680,449 | $4,301,949 | 0.00% |
| ATLAS CAPITAL ADVISORS LLC | 896 | $2,293 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 16,915 | $43,302 | 0.00% |
| VANGUARD GROUP INC | 1,752,594 | $4,486,641 | 0.00% |
| Qube Research & Technologies Ltd | 2,410 | $6,170 | 0.00% |
| Renaissance Technologies | 17,700 | $45 | 0.00% |
| UBS Group AG | 1,115 | $2,854 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 200 | $512 | 0.00% |
| STIFEL FINANCIAL CORP | 116,900 | $299,264 | 0.00% |
| WELLS FARGO & COMPANY/MN | 286 | $732 | 0.00% |
| NORTHERN TRUST CORP | 71,976 | $184,259 | 0.00% |
This page lists TSCAN THERAPEUTICS INC's shareholders in Q3 2023. To view TSCAN THERAPEUTICS INC's shareholder history, click here.